The new corona virus SARS-CoV-2 has been raging since January 2020, spreading at an unprecedented pace, exhibiting insidious properties and puzzling experts. SCHURTER has taken this fact into account and has ramped up the production of its medical products.
Thanks to decades of expertise in manufacturing as a supplier of medical technology, SCHURTER was able to avert the lockdown of many of its production facilities. Pandemic and system-relevant plants were closed in very few countries.
SCHURTER took advantage of this situation and decided to drastically increase its capacities in favour of the production of components and input systems for medical technology.
PeakSpan Capital leads, joined by Vertex Ventures and Horizon Capital, as commercial and operations leaders…
New Sinamics G series creates a seamless platform for continuous-motion applications Security by Design helps…
See Samtec’s solutions in Hall B2, Booth 107 Samtec, Inc., the service leader in the…
Acquisition adds NeuReality's AI inference technology and world-class systems and silicon engineering team, compressing the…
The edgeRX Starter predictive maintenance (PdM) solution is now available at DigiKey.com DigiKey, the global…
The global distributor will also demo top products from Arduino, DFRobot, SparkFun and more DigiKey,…